Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias.

Disease markers - 1 Jan 2005

Goebel Georg, Zitt Marion, Zitt Matthias, Müller Hannes M

Abstract excerpt

It is now widely accepted that there is a need for the development of molecular markers of cancer that can be used for clinical prognostication and monitoring. Approximately a decade ago tumor-derived circulating nucleic acids in the plasma or serum (CNAPS) of cancer patients were introduced as a noninvasive tool for cancer detection. This review focuses on the various types of CNAPS of patients with solid...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell-Free System
Share to DNA Methylation
Share to DNA, Mitochondrial

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA, Viral

Share to Neoplastic Cells, Circulating

Share to Nucleic Acids

Share to Nucleosomes

Share to RNA, Viral

Source

Open in PubMed Open full text

Identifiers

PMID: 16276004
DOI: 10.1155/2005/218759
PMCID: PMC3851114

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Circulating nucleic acids in plasma or serum (CNAPS) as prognostic and predictive markers in patients with solid neoplasias.PMID 16276004Read ↗

Circulating nucleic acids as a tumor marker.Semantic proximity Read ↗

Circulating nucleic acids as a potential source for cancer biomarkers.Semantic proximity Read ↗

Circulating Tumor DNA as Biomarkers for Cancer DetectionSemantic proximity Read ↗

Recent advances in circulating nucleic acids in oncologySemantic proximity Read ↗

Circulating Tumor DNA in Cancer Management.Semantic proximity Read ↗

Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?Semantic proximity Read ↗

Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection TechniquesSemantic proximity Read ↗

ctDNA as a Cancer Biomarker: A Broad OverviewSemantic proximity Read ↗

Revolution of Circulating Tumor DNA: From Bench Innovations to Bedside ImplementationsSemantic proximity Read ↗

ctDNA as a cancer biomarker: A broad overview.Semantic proximity Read ↗

Plasma nucleic acids in the diagnosis and management of malignant disease.Semantic proximity Read ↗

Circulating Tumor DNA as a Cancer Biomarker: An Overview of Biological Features and Factors That may Impact on ctDNA AnalysisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.